Zayo will acquire the fiber business for $4.25 billion, and EQT will purchase the small cell segment for the same amount. The transaction is expected to close in the first half of 2026.

Our initial indication is in idiopathic small fiber neuropathy, or iSFN, a peripheral neuropathy that results in highly debilitating symptoms such as burning, prickling, stabbing or lightning like ...

an epigenetic regulator for the treatment of a type of chronic pain called idiopathic small fiber neuropathy, into a phase 1/2 trial by the middle of this year. Editor's note: This story was ...

Idiopathic normal pressure hydrocephalus (INPH) is characterized by gait disturbance, cognitive deterioration and urinary incontinence, and is associated with ventricular enlargement in the ...

Hyderabad’s peripheral markets will add 12-15% of Grade A office space, with Metro Phase 2 driving growth and property prices rising 10-20% Hyderabad's real estate sector, especially in ...

Muscle strengthening and balance training alleviate chemotherapy-induced peripheral neuropathy. Moreover, some research suggests engaging in physical activity at the start of chemotherapy prevents the ...